ING Groep NV Takes Position in Henry Schein, Inc. (NASDAQ:HSIC)

ING Groep NV purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the third quarter, Holdings Channel.com reports. The institutional investor purchased 867,302 shares of the company’s stock, valued at approximately $63,226,000.

A number of other institutional investors have also recently bought and sold shares of HSIC. Cromwell Holdings LLC increased its holdings in shares of Henry Schein by 93.4% during the 3rd quarter. Cromwell Holdings LLC now owns 352 shares of the company’s stock worth $26,000 after acquiring an additional 170 shares during the last quarter. Summit Securities Group LLC bought a new position in Henry Schein during the second quarter worth $31,000. Beach Investment Counsel Inc. PA acquired a new position in shares of Henry Schein in the second quarter valued at $37,000. Blue Trust Inc. raised its position in shares of Henry Schein by 104.2% in the second quarter. Blue Trust Inc. now owns 931 shares of the company’s stock valued at $60,000 after purchasing an additional 475 shares during the period. Finally, Farther Finance Advisors LLC lifted its stake in shares of Henry Schein by 58.9% during the 3rd quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after buying an additional 346 shares during the last quarter. Institutional investors and hedge funds own 96.62% of the company’s stock.

Analyst Ratings Changes

A number of brokerages recently commented on HSIC. Robert W. Baird decreased their price target on shares of Henry Schein from $92.00 to $82.00 and set an “outperform” rating on the stock in a research note on Wednesday, August 7th. Barrington Research reiterated an “outperform” rating and set a $82.00 target price on shares of Henry Schein in a research note on Wednesday, November 6th. StockNews.com raised Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. JPMorgan Chase & Co. decreased their price objective on Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a report on Monday, August 12th. Finally, Baird R W raised Henry Schein from a “hold” rating to a “strong-buy” rating in a report on Monday, July 22nd. One equities research analyst has rated the stock with a sell rating, six have given a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of $77.50.

Insider Transactions at Henry Schein

In related news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The stock was sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Company insiders own 1.14% of the company’s stock.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded down $0.97 during trading hours on Thursday, hitting $66.77. 368,756 shares of the stock were exchanged, compared to its average volume of 1,347,771. Henry Schein, Inc. has a 1-year low of $63.67 and a 1-year high of $82.63. The company has a market cap of $8.32 billion, a PE ratio of 27.88, a price-to-earnings-growth ratio of 1.93 and a beta of 0.87. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The company’s fifty day simple moving average is $70.37 and its two-hundred day simple moving average is $69.62.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, November 5th. The company reported $1.22 EPS for the quarter, topping the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion during the quarter, compared to the consensus estimate of $3.24 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business’s quarterly revenue was up .4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.32 earnings per share. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.78 EPS for the current year.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.